Market Overview:
The global alkylating agents market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for targeted therapies, and growing preference for oral administration over intravenous administration. Based on type, the global alkylating agents market can be segmented into oral route and intravenous route. The oral route segment is expected to account for a larger share of the global market than the intravenous route segment during the forecast period. This can be attributed to factors such as lower cost and ease of use compared with intravenous administration. Based on application, the global alkylating agents market can be divided into hospital pharmacies, retail pharmacies, online retailers, and private clinics.
Product Definition:
Alkylating agents are a class of anticancer drugs that work by interfering with the ability of cancer cells to divide and grow.
Oral Route:
Oral route is the most preferred route of administration in chemotherapy. It has been observed that majority of cancer patients prefer taking medication by mouth. This trend is increasing the demand for oral drugs as compared to injectable and other routes of administration.
Oral Route, it's usage.
Intravenous Route:
Intravenous route is the most common and primary mode of administration for alkylating agents. Intravenous route is preferred over oral or intramuscular routes owing to higher bioavailability, lesser adverse effects, and lower toxicity levels. The intravenous route allows rapid onset of action with a shorter half-life compared to other routes of administration.
Application Insights:
The application segment includes hospital pharmacies, retail pharmacies, online retailers and private clinics. Hospital pharmacies accounted for the largest share in 2015 owing to the high usage of intravenous alkylating agents for chemotherapy in hospitals. The use of these agents also allows chemotherapeutic drugs to be administered at a higher dosage rate which results in an increased revenue generation capacity for this segment.
Retail pharmacy is expected to be the fastest-growing application segment over the forecast period due to increasing awareness about cancer and its treatment among consumers as well as healthcare professionals. Moreover, growing demand from end-users is anticipated to further boost growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing incidence of cancer and other diseases, presence of key companies, and availability of advanced healthcare facilities. Moreover, rising awareness regarding treatment options is also one of the major factors responsible for regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels in emerging economies such as China & India coupled with growing health concerns among consumers resulting in increased adoption of alkylating agents for treatment purposes. In addition, increasing prevalence rate for various cancers including bladder & liver carcinoma are also contributing towards regional demand (estimated around 1 million new cases per year).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the global alkylating agents market. According to the World Health Organization (WHO), an estimated 14 million new cases of cancer were diagnosed in 2012, and this number is expected to rise to 24 million by 2030. This will create a high demand for alkylating agents as they are used in the treatment of various types of cancers.
- Rising awareness about cancer treatments: There is a growing awareness among people about different types of cancers and their treatments. This has led to an increase in demand for alkylating agents, as they are one of the most commonly used treatments for various types of cancers.
- Technological advancements in alkylation therapies: There have been significant advancements made in technology that has helped improve the efficacy and safety profileofalkylation therapiesusedforthetreatmentofcancer patients .Thiswillhelpdriveupthedemandforalkylatingagentsin themarketplace .
Scope Of The Report
Report Attributes
Report Details
Report Title
Alkylating Agents Market Research Report
By Type
Oral Route, Intravenous Route
By Application
Hospital Pharmacies, Retail Pharmacies, Online Retailers, Private Clinics
By Companies
Merck & Co., Inc., Cipla Inc., Pfizer Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Alkylating Agents Market Report Segments:
The global Alkylating Agents market is segmented on the basis of:
Types
Oral Route, Intravenous Route
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Retailers, Private Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck & Co., Inc.
- Cipla Inc.
- Pfizer Inc.
Highlights of The Alkylating Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Route
- Intravenous Route
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Retailers
- Private Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alkylating Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alkylating agents are a type of chemotherapy that work by damaging the DNA in cells. This can lead to cell death.
Some of the key players operating in the alkylating agents market are Merck & Co., Inc., Cipla Inc., Pfizer Inc..
The alkylating agents market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alkylating Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alkylating Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alkylating Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alkylating Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alkylating Agents Market Size & Forecast, 2018-2028
4.5.1 Alkylating Agents Market Size and Y-o-Y Growth
4.5.2 Alkylating Agents Market Absolute $ Opportunity
Chapter 5 Global Alkylating Agents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Alkylating Agents Market Size Forecast by Type
5.2.1 Oral Route
5.2.2 Intravenous Route
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Alkylating Agents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Alkylating Agents Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Retailers
6.2.4 Private Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alkylating Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alkylating Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Alkylating Agents Analysis and Forecast
9.1 Introduction
9.2 North America Alkylating Agents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Alkylating Agents Market Size Forecast by Type
9.6.1 Oral Route
9.6.2 Intravenous Route
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Alkylating Agents Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Retailers
9.10.4 Private Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Alkylating Agents Analysis and Forecast
10.1 Introduction
10.2 Europe Alkylating Agents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Alkylating Agents Market Size Forecast by Type
10.6.1 Oral Route
10.6.2 Intravenous Route
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Alkylating Agents Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Retailers
10.10.4 Private Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Alkylating Agents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Alkylating Agents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Alkylating Agents Market Size Forecast by Type
11.6.1 Oral Route
11.6.2 Intravenous Route
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Alkylating Agents Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Retailers
11.10.4 Private Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Alkylating Agents Analysis and Forecast
12.1 Introduction
12.2 Latin America Alkylating Agents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Alkylating Agents Market Size Forecast by Type
12.6.1 Oral Route
12.6.2 Intravenous Route
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Alkylating Agents Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Retailers
12.10.4 Private Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Alkylating Agents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Alkylating Agents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Alkylating Agents Market Size Forecast by Type
13.6.1 Oral Route
13.6.2 Intravenous Route
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Alkylating Agents Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Retailers
13.10.4 Private Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alkylating Agents Market: Competitive Dashboard
14.2 Global Alkylating Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck & Co., Inc.
14.3.2 Cipla Inc.
14.3.3 Pfizer Inc.
